Insu-Stabilize contains 7 ingredients and 4 major patents. It is characterized by using high-quality ingredients for the intestines, blood and cells to achieve comprehensive sugar control, assisting blood sugar to achieve stability, regulation, metabolism and balance.
The main functional ingredient Insumate®(containing the patented amino peptide sequence mcIRBP-19) were researched by Taiwan R&D team and medical R&D doctoral group from Taiwan authoritative medical school. It took more than 12 years, and at least 2 large-scale clinically trial. It has been published in scientific literature to prove that its function helps to control sugar, promote metabolism, adjust physical fitness and maintain health.
In addition, with other ingredients to coordinate sugar management,fenugreek seeds extract, gymnema sylvestre extract and mulberry leaf extract can help delay the absorption of carbohydrates in the diet; bitter melon extract and cinnamomi cortex extract help insulin efficacy in the body, which is beneficial for stabilizing blood sugar; finally , Chromium Picolinate and Zinc yeast contribute to the normal metabolism of carbohydrates. Insu-Stabilize help to accurately control sugar management and normal metabolism, and give consumers a high-quality and meaningful new health experience.

• New Dietary Ingredient (NDI) Notification

• Food Safety System Certification 22000

• Good Manufacturing Practice

• Hazard Analysis and Critical Control Points

• ISO22000(Food Safety Management Systems — Requirements for Any Organization in the Food Chain)

Active Ingredients:
Insumate®Bitter melon extract(containing peptide sequence mcIRBP-19)、Cinnamoni Cortex extract、Gymnema Sylvestre extract、Mulberry leaf extract、Fenugreek seed extract、Zinc yeast、Chromium Picolinate、Thiamine Hydrochloride(Vitamin B1)
Capsule Ingredients:
Hydroxypropyl methylcellulose、Purified water、Carrageenan、Titaniumd ioxide、Potassium chloride

Key active indicators per serving:
1.Insumate®Bitter melon extract(MCIRPBP-19≥800ppm):150mg
2.Cinnamoni Cortex extract(Type-A Polymers≥3%):80mg
3.Gymnema Sylvestre extract(Gymnemic acid>25%):80mg
4.Mulberry leaf extract(Flavone≥10%):50mg
5.Fenugreek seed extract(Total Dietary Fiber85%, Soluble Dietary Fiber75%):50mg

6.Zinc yeast(Zinc 100000-120000ppm) :10mg
7.Chromium Picolinate(Chromium12.18~12.68%) :0.78mg

HUA XIN INTERNATIONAL MEDICINE CO., LTD.

1.Incoming Quality Control (IQC): Gatekeeping at the Source We enforce strict source management by verifying the Certificate of Analysis (COA) for every batch of incoming raw materials. In tandem, independent sampling and testing (including organoleptic and physical properties) are conducted. Materials are only cleared for warehousing upon meeting all criteria, establishing a comprehensive batch-traceability system. In-Process 

2.Quality Control (IPQC): Manufacturing Process Monitoring We conduct rigorous on-site process audits in strict accordance with the Manufacturing & Quality Control Process Flow Diagram. During production, critical control points (CCPs) such as "blending uniformity" and "capsule filling weight variation" are sampled at scheduled intervals to proactively prevent and rectify any process deviations, ensuring consistent quality. Final 

3.Quality Control (FQC): Terminal Release Control We implement a stringent final quality gate. Every batch of finished, packaged products must undergo comprehensive testing across physicochemical properties, safety indicators, and microbial levels. A Finished Product Certificate of Analysis (COA) will only be issued for release and shipment once all test items are confirmed fully compliant.

• SGS Heavy Metals Testing (As, Pb, Cd, Hg)

• SGS Microbial Testing (Total plate count, Coliforms, E. coli)

• SGS 410 Pesticide Residues Testing

• SGS Microorganisms Testing (Salmonella and Staphylococcus aureus)

• SGS 365 Western Medicine Testing

• Raw Material Acceptance:Control items include appearance, color, moisture content, microbial levels, and heavy metals. 
   

• In-Process Blending Verification:Control items include sifting (to ensure no foreign matter), magnetic separation (to ensure no metallic foreign matter), appearance, moisture content, and weight.

• Empty Capsule Acceptance:Control items include appearance, average weight, moisture content, total aerobic microbial count (TAMC), E. coli, and Salmonella.

• Capsule Filling Process:Control items include fill weight, appearance, and capsule weight.

• Packaging Material Acceptance:Control items include thickness, dimensions, appearance, material composition, and migration/dissolution testing.

• Finished Product Testing:Control items include appearance, contents analysis, moisture content, weight, Staphylococcus aureus, Salmonella, E. coli, and coliforms.

Formulated with 7 key ingredients and 4 core patents, this product delivers comprehensive blood sugar management to support stability, regulation, and metabolism, while restoring body balance.
The star ingredient, Insumate® (a patented 19-peptide sequence), was co-developed by leading Taiwanese medical schools and Ph.D. research teams. Backed by extensive clinical studies and published literature, it is scientifically proven to promote blood sugar stability, boost metabolism, and regulate overall physical well-being.

• Yang , Y.-S., Wu , N.-Y., Kornelius , E., Huang , C.-N., & Yang , N.-C. (2022). A randomized, double-blind, placebo-controlled trial to evaluate the hypoglycemic efficacy of the mcIRBP-19-containing

• Hsu PK, Pan FFC, Hsieh CS. mcIRBP-19 of Bitter Melon Peptide Effectively Regulates Diabetes Mellitus (DM) Patients' Blood Sugar Levels. Nutrients. 2020 Apr 28;12(5):1252. doi: 10.3390/nu12051252. PMID: 32354072; PMCID: PMC7281988.

• Taiwan Patent:No.I342781

• Switzerland Patent:No.EP2191837

• Italy Patent:No.EP2191837

• Germany Patent:No.EP2191837

• European Patent (EPO):No.EP2191837

• France Patent:No. EP2191837

• United Kingdom Patent:No.EP2191837

• United States Patent:No.US8476229

• Japan Patent:No.6116539